Back | Next |
home / stock / eton / eton message board
Subject | By | Source | When |
---|---|---|---|
Eton Pharmaceuticals Announces FDA Approval of ZONISADE (Zonisamide | subslover | investorshub | 07/18/2022 12:11:00 PM |
Upgraded Buy Target | Vance | investorshub | 10/01/2020 1:55:01 PM |
And more in the pipeline | Glider549 | investorshub | 09/30/2020 12:26:50 AM |
Eton Pharmaceuticals Announces FDA Approval of Orphan Drug | Amatuer17 | investorshub | 09/29/2020 11:51:24 PM |
Tomorrow is the day! | Glider549 | investorshub | 09/28/2020 11:23:43 PM |
Next one is next week 29th Sept | Amatuer17 | investorshub | 09/25/2020 3:28:56 PM |
Finally first of the 2 approval | Amatuer17 | investorshub | 09/25/2020 3:23:23 PM |
$138k buy at $8.12 3pm central time. | bcnuby1 | investorshub | 09/17/2020 8:06:35 PM |
Today is the new PDUFA date for one | Amatuer17 | investorshub | 09/15/2020 3:18:07 PM |
Attention Biotech Investors: Mark Your Calendar For September | stockguard | investorshub | 09/05/2020 4:48:31 PM |
Maybe today then :-) | Toddrobertking | investorshub | 08/12/2020 10:40:02 AM |
This gets approved today!!! 50-100% spike? | Toddrobertking | investorshub | 08/11/2020 3:23:06 PM |
https://etonpharma.com/eton-pharma-business-model/ | barnyarddog | investorshub | 08/01/2020 12:50:30 AM |
MAJOR Breakout imminent guys | BioSpecialist | investorshub | 06/01/2020 6:03:03 PM |
ETON =MC $96 M--3x FDA DECISIONS in this | BioSpecialist | investorshub | 06/01/2020 1:27:40 PM |
It's a month out from the fda decision. | pijoe | investorshub | 02/17/2020 11:40:50 AM |
Theres more meat on this bone. Took some | grich1 | investorshub | 12/26/2019 8:26:08 PM |
What a joke. This is truly pathetic! | TheWhaleStreet | investorshub | 10/25/2019 1:20:22 AM |
* * $ETON Video Chart 10-22-2019 * * | ClayTrader | investorshub | 10/22/2019 9:43:12 PM |
I'm out -- broke even. Good luck if | Pedro2004 | investorshub | 10/22/2019 1:33:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Eton Pharmaceutcials Inc. Company Name:
ETON Stock Symbol:
NASDAQ Market:
Eton Pharmaceutcials Inc. Website:
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13 th straight quarter of sequential product sales growth • Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
2024-05-06 09:00:05 ET Chase Knickerbocker from Craig-Hallum issued a price target of $8.00 for ETON on 2024-05-06 07:29:00. The adjusted price target was set to $8.00. At the time of the announcement, ETON was trading at $3.71. The overall price target consensus is at $...